Revenue in the Vitamins & Minerals segment Europe 2024

The revenue in the Vitamins & Minerals segment of the over the counter pharmaceuticals market in Europe was forecast to continuously increase between 2024 and 2029 by in total 1.7 billion U.S. dollars (+33.2 percent). After the thirteenth consecutive increasing year, revenue is estimated to reach 6.79 billion U.S. dollars and therefore a new peak in 2029.

Revenue in the Vitamins & Minerals segment of the otc pharmaceuticals market Europe from 2016 to 2029 (in billion U.S. dollars)

Characteristic	In billion U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

Definition:
The Vitamins and Minerals market comprises over-the-counter natural and synthetic food supplements like multivitamin preparations, minerals, vitamins, tonics and cod liver oil. Vitamins and minerals include preparations in the form of capsules, dragees, pills, granulate, ampoules, solutions, powders, syrups for oral use. Not included are prescription medicines, preparations that are not explicit food supplement drugs (e.g. muscle-building preparations) or primarily serve cosmetic purposes. Among the top-selling vitamin and mineral products are Vitasprint, Orthomol, magnesium granulate, Curazink, Centrum. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Citation formats